TGFB1 and cancer: The co-receptor-dependent targeting of the TGF-β pathway with both agonists and antagonists by the helminth H. polygyrus provides both a vivid illustration of pathogen evolutionary innovation, and an instructive template for the development of effective therapies for targeting the cancer and fibrosis-promoting activities of the TGF-βs in humans.